Insider · CIK 0002042266
Foundation Fighting Blindness Retinal Degeneration Fund
Files at IRD (Opus Genetics, Inc.). First filing Dec 11, 2025, latest Oct 2, 2026.
Foundation Fighting Blindness Retinal Degeneration Fund files SEC Form 4 as director and 10% owner at IRD (Opus Genetics, Inc.). Since Dec 11, 2025, Foundation Fighting Blindness Retinal Degeneration Fund has reported 0 open-market buys worth $0 and 2 open-market sells worth $11M, the latest filed on Oct 2, 2026.
A track record needs three past buys with six months of prices behind them; Foundation Fighting Blindness Retinal Degeneration Fund has 0, so none is measured yet.
The newest scored trade: sold $2.8M of IRD on Sep 30, 2026, filed Oct 2, 2026, scored 45 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $11M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IRD: Opus Genetics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | IRDsell Opus Genetics, Inc. | $2.8M 556,000 shares | -15% | +193% from low-20% from high | |
| 50Moderate | IRDsell Opus Genetics, Inc. | $8.6M 4,000,000 shares | -42% | +237% from low0% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | IRD Opus Genetics, Inc. | SOpen-market sale Common Stock | -556,000 | $4.96 | $2.8M | 3,236,171 | 11 d ago |
| Dec 9, 2025 | IRD Opus Genetics, Inc. | SOpen-market sale Common Stock | -4,000,000 | $2.15 | $8.6M | 5,492,171 | Dec 11, 2025 |
| May 5, 2025 | IRD Opus Genetics, Inc. | CConversion Common Stock | +6,927,419 | - | - | 9,492,171 | May 6, 2025 |
| May 5, 2025 | IRD Opus Genetics, Inc. | CConversion Series A Non-Voting Convertible Preferred Stockderivative | -6,927 | - | - | 0 | May 6, 2025 |
Questions about Foundation Fighting Blindness Retinal Degeneration Fund
Answered from the filings on this page, as of the latest one.
Is Foundation Fighting Blindness Retinal Degeneration Fund buying or selling?
In the last 12 months Foundation Fighting Blindness Retinal Degeneration Fund reported 0 open-market buys worth $0 and 2 open-market sells worth $11M on SEC Form 4; the latest was sold $2.8M of IRD on Sep 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Foundation Fighting Blindness Retinal Degeneration Fund's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Foundation Fighting Blindness Retinal Degeneration Fund has 0.
Where does Foundation Fighting Blindness Retinal Degeneration Fund file Form 4?
Foundation Fighting Blindness Retinal Degeneration Fund has filed Form 4 at IRD (Opus Genetics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.